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ABSTRACT: In this work, the ability of gellan gum hydrogels coupled with autologous cells to regenerate rabbit full-thickness articular
cartilage defectswas tested. Five studygroupswere defined: (a) gellan gumwith encapsulated chondrogenic predifferentiated rabbit adipose
stem cells (ASCþGF); (b) gellan gumwith encapsulated nonchondrogenic predifferentiated rabbit adipose stem cells (ASC); (c) gellan gum
with encapsulated rabbit articular chondrocytes (AC) (standard control); (d) gellan gum alone (control); (e) empty defect (control). Full-
thickness articular cartilage defectswere created and the gellan gumconstructswere injected and left for 8weeks. Themacroscopic aspect of
the explants showed a progressive increase of similarity with the lateral native cartilage, stable integration at the defect site, more
pronouncedly in the cell-loaded constructs. Tissue scoring showed that ASCþGF exhibited the best results regarding tissue quality
progression. Alcian blue retrieved similar results with a better outcome for the cell-loaded constructs. Regarding real-time PCR analyses,
ASCþGF had the best progression with an upregulation of collagen type II and aggrecan, and a downregulation of collagen type I. Gellan
gum hydrogels combined with autologous cells constitute a promising approach for the treatment of articular cartilage defects, and adipose
derived cellsmay constituteavalidalternative to currentlyusedarticular chondrocytes. !2010OrthopaedicResearchSociety.Publishedby
Wiley Periodicals, Inc. J Orthop Res 28:1193–1199, 2010
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Articular cartilage is considered to be the most
important type of cartilage due to its function in
mobility and locomotion. Due to the tissues’ intrinsic
features (low metabolism, absence of vascularization),
trauma and degenerative conditions (e.g., focal defects,
osteoarthritis, rheumatoid arthritis) frequently create
disability states leading to pain and decreased
life quality. Although several therapies have been
attempted, the outcomes are not fully satisfactory, and
other lines of research have been put forward.1–3 The
use of biomaterials, cells and bioactive agents, either
alone or combined, has been proposed4–6 as an alter-
native to solve these problems, being this field defined as
tissue engineering.7 Natural and synthetic biomaterials
have been studied as supports for cell development and
formation of a functional cartilaginous tissue.8,9 Hydro-
gels in the form of injectable systems that can be applied
in a minimally invasive manner gelling in situ under
physiological conditions have gathered considerable
attention in cartilage regeneration approaches.10,11
Gellan gum is a polysaccharide that forms thermor-
eversible gels, being noncytotoxic in different tested
situations.12–14 It is commonly applied in the food
industry,15 and has been previously used in the
biomedical field for drug delivery.16 Gellan gum has
been originally proposed by our group17 as a new
biomaterial for cartilage tissue engineering applica-
tions, yet recent studies can be found on the same
application18 and on the general use of gellan gum for
tissue engineering.19 In our previous works, it has been
used to encapsulate both human nasal and articular
chondrocytes in vitro, and has been tested in vivo by
subcutaneous implantation in nude mice with human
articular chondrocytes.20–22 In this work, autologous
cells [adipose stem cells (ASC) articular chondrocytes
(AC)] were combined with gellan gum and injected in
rabbit knee full thickness size defects. The results show
that gellan gum constructs are able to efficiently
regenerate hyaline-like cartilage tissue in the created
defects.
METHODS
Five groups were defined for this work: (a) gellan gum with
encapsulated chondrogenic predifferentiated [transforming
growth factor beta1 (TGF-b1) and bone morphogenetic protein
2 (BMP-2)] rabbit adipose stem cells (ASCþGF); (b) gellan
gum with encapsulated nonchondrogenic predifferentiated
rabbit adipose stem cells (ASC); (c) gellan gum with encapsu-
lated rabbit articular chondrocytes (AC) (standard control);
(d) gellan gum alone (GELLAN) (control); (e) empty defect
(EMPTY) (control). A total of 12 New Zealand White rabbits
(n¼ 12) were used, 4 per time point (1, 4, and 8 weeks), and
each rabbit had a total of 4 defects created in the same way in
the right limb. The experiments with the model involved an
autologous approach, meaning that the cells extracted from a
specific rabbit were implanted in the same rabbit. The animal
tests were approved by the Ethics Review Committee and their
care was in accordance with institution guidelines.
Rabbit Adipose Stem Cells Isolation and Expansion
Rabbit adipose tissue was obtained from the intrascapular
region of 10–11 weeks old/2.4–2.6 kg female New Zealand
White rabbits. Charles Rives, Barcelona, Spain Briefly, the
rabbits were preanaesthetized with ketamine (25mg/kg i.m.,
Imalgene1 1000, Merial, Lyon, France) and medetomidine
(0.15ml/kg i.m., Domitor1, Orion Corporation, Espoo, Fin-
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land). Adipose tissue was collected and digested in a 1mg/ml
collagenase type II (Sigma-Aldrich Co., St. Louis, MO)
solution, and the released cells ressuspended in culture
medium [Dulbecco’s modified Eagle’s medium (DMEM)
(Sigma-Aldrich Co., St. Louis, MO), 10% (v/v) fetal bovine
serum (FBS, Biochrom, Berlin, Germany; Heat Inactivated),
1% antibiotic], and seeded in tissue culture polystyrene flasks
for expansion. The cells were divided in two groups: one group
subjected to a chondrogenic predifferentiation period consist-
ing of DMEM, sodium pyruvate 1.0# 10$3M, ascorbate-2-
phosphate 0.17mM, proline 0.35mM, ITS 1X, and supple-
mented with 10ng/ml TGF-b1 (Sigma-Aldrich Co., St. Louis,
MO) for 2 days followed by 100ng/ml BMP-2 (R&D Systems,
Minneapolis, MN) for 3 days prior to in vivo implantation
(ASCþGF); another group cultured with the same medium
but without TGF-b1 and BMP-2 (ASC).
Rabbit Articular Chondrocytes Isolation and Expansion
The chondrocytes isolation and expansion protocol was based
on previous reports from Crawford and Dickinson.23 Rabbits
were preanaesthetized as detailed before for adipose tissue
collection. Fragments of articular cartilage were harvested
from the femoral condyles and the cartilage pieces immersed in
trypsin–EDTA solution, followed by a DMEM and sterile
collagenase type II solution (2mg/ml) and kept for 8–10h at
378C under constant agitation. The isolated cells were
suspended in expansion medium consisting of DMEM, con-
taining 10mM HEPES buffer pH 7.4, 1% antibiotic, 20mM L-
alanyl glutamine, 1# MEM nonessential amino acids and
10% (v/v) FBS (Biochrom Berlin, Germany; Heat Inacti-
vated), supplemented with 10ng/ml basic fibroblast growth
factor (bFGF) (PeproTech, London, UK). Rabbit articular
chondrocytes were plated into tissue culture flasks for
expansion.
In Vivo Injection in Rabbit Articular Cartilage Defects of Gellan
Gum-Cell Constructs
The different cells were used at passage 2 under the following
procedure. Gellan gum powder (G1910, Sigma-Aldrich Co., St.
Louis, MO) was mixed with sterile distilled water to obtain a
final concentration of 1.25% (w/v). The solution was stabilized
at 428C under constant stirring. Articular cartilage full-
thickness defects with a diameter of 4mm were created in
the rabbits medial femoral condyle and a 1mm diameter hole
was drilled to the subchondral bone (Fig. 1). Briefly, the rabbits
were preanaesthetized with ketamine (25mg/kg i.m., Imal-
gene1 1000,Merial, Lyon, France) andmedetomidine (0.15ml/
kg i.m., Domitor1, Orion Corporation, Espoo, Finland). The
cells were ressuspended in a small amount of PBS, the gellan
gum solution was mixed at a temperature of 40–418C with the
cell suspension (final concentration of 10# 106 cells/ml) and
the mixture was then injected into the defect. A waiting time of
2–3min was given for the gels to form in situ. Defects were
also filled with gellan gumwithout cells and other defects were
left empty. The experiments were conducted for periods of up
to 8 weeks with data collection points at 1, 4, and 8 weeks. At
the established time points, the animals were euthanized by
injection of an overdose of pentobarbital sodium (Eutasil1
Ceva Sante Animale, Libourne, France).
Histology and Histological Scoring
Common histological analysis was performed on 4 mm thick-
ness sections of the samples collected after 1, 4, and 8 weeks of
implantation. The explants were dehydrated, embedded in
paraffin and cut for posterior analysis using a microtome Leica
RM2155 (Leica Microsystems, Nussloch, Germany). H&E
staining was performed using an automatic processor accord-
ing to in-house methodology (Leica TP1020-1, Leica Micro-
Systems, Nussloch, Germany) and alcian blue staining
followed standard histological methods. The Pineda scoring
system24 was used for histological evaluation of the explants.
The degree and the quality of healing in all defects was
assessed and scored blindly by five independent researchers.
The maximum possible score in the Pineda scoring system is 0
points (increased regenerative potential) with a minimum of
14 points (decreased regenerative potential). Statistical anal-
yses were conducted using SPSS Statistics 17.0 software,
namely one-way ANOVA with Tukey correction for n¼ 5.
Statistical significance level was p< 0.05 and the test of
homogeneity of variances confirmed for p< 0.05.
Real-Time PCR (Sox9, col I, col II, Aggrecan)
Samples were collected after 1, 4, and 8 weeks of implantation
upon exposure of the defect site area. They were immersed in
TRIzol1 (Invitrogen, Carlsbad, CA), and stored at $808C for
posterior analysis. RNA was extracted following the manu-
facturers’ guidelines. The amounts of isolated RNA and A260/
280 ratio were determined using Nanodrop ND-1000 Spec-
trophotometer (NanoDrop Technologies, Inc., Rockland, DE).
A predetermined amount of RNA from each sample was
reverse transcribed into cDNA using the IScriptTM cDNA
synthesis kit (Bio-Rad Laboratories, Hercules, CA) in a BioRad
CFX96 real-time PCR detection system (Bio-Rad Laboratories,
Hercules, CA). Cartilage related markers (Sox9, collagen type
I, collagen type II, and aggrecan, using GAPDH as the
housekeeping gene for normalization) were chosen to evaluate
the chondrogenic phenotype of the cultured systems. The
relative gene expression quantification was performed using
the 2$!!Ct (Livak) method. All the primer sequences were
generated using Primer3 software25 and acquired from MWG
Biotech AG (Ebersberg, Germany). Real-time PCR was
performed using a BioRad CFX96 real-time PCR detection
system (Bio-Rad Laboratories, Hercules, CA) and SYBR Green
IQTM Supermix (Bio-Rad Laboratories, Hercules, CA) to
detect amplification variations. The analyses of the results
were performed with CFX Manager Software—version 1.0
(Bio-Rad Laboratories, Hercules, CA).
RESULTS
Macroscopic Observation and Histology
Macroscopic observation of the defects shows a smooth
lateral integration and homogeneous appearance of the
cell containing constructs, namely both groups of tested
ASC, and also articular chondrocytes (Fig. 2). The
results presented in Figure 3 show that the injected
gellan gum hydrogels containing the different cell types
studied were kept in the defect after injection and
appear to be well integrated, both in the osteochondral
junction and with the lateral native articular cartilage.
Figure 1. Schematic representation of the articular cartilage
defect created in the rabbits femoral condyles.
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This observation is evident in all the constructs with the
exception of gellan gum alone where the inclusion and
integration is apparently weaker. Regarding cell mor-
phology, similar results were found for ASCþGF and
ASC, with the constructs containing AC presenting a
slightly different phenotype when compared to the
native cartilage. Gellan gum alone and the empty defect
presented the less similar morphologies, exhibiting only
some focal spots of hyaline-like chondrocytes, which
were detected more frequently in gellan gum hydrogels
alone. Alcian blue methacromatic staining was detected
in histological sections of all the explants, although
with different extents (Fig. 4). Regarding the regularity
of the staining profiles, gellan gum with ASCþGF and
ASC appear to be the most uniform extending from the
center of the defect site to the contact with the lateral
cartilage present on each side. Some implantation sites
(Fig. 3) presented evidences of tissue formation out of
the articular plane, which may be an indirect result of
the biopsy taken for real-time PCR analysis which
morphologically altered the explants to some extent, or
excess of hydrogel-cell constructs being injected in the
defect.
Histological Scoring
The Pineda scoring system26,27 was used to grade the
tissue quality of the various groups in study. ASCþGF
exhibited the best absolute values in terms of pro-
gression of a newly formed hyaline-like cartilage
tissue (Fig. 5). When looking to the scores for 1, 4, and
8 weeks of implantation, ASCþGF constructs show a
continuous increase in performance culminating at the
final time point where they were ranked the best
within the five groups. Gellan gum hydrogels with
encapsulated ASC have demonstrated some variability
throughout the implantation stages, but considerably
improved after 8 weeks. The variations within AC
constructs occurred in a smoother way presenting a
better performance after 8 weeks. The gellan gum
hydrogels alone showed slightly increasing quality of
the newly formed tissue, maintaining nevertheless
some stability in terms of the scoring. Finally, the
empty defects exhibited an improvement tendency
with time more noticeable at 4 weeks of implantation.
From 4 to 8 weeks, no relevant variations are encoun-
tered and this group was ranked the poorest regarding
the quality and performance, being statistically differ-
ent from the cell-loaded constructs (p<0.05).
Real-Time PCR (Sox9, Collagen Type I,
Collagen Type II, Aggrecan)
The real-time PCR analyses results are graphically
represented in Figure 6. In the gellan gum hydrogels
with encapsulated ASCþGF, no Sox9 expression was
Figure 2. Macroscopical obser-
vation of the different studied
groups after 1 and 8 weeks post-
implantation.
Figure 3. Optical microscopy
pictures of histological sections of
the explants after 8 weeks of
culture and stainedwith hematox-
ylin–eosin (I, implant region;
NC, native cartilage; scale bar¼
200mm).
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detected. Collagen type I levels were residual at 4 weeks
and were not observed after 8 weeks of implantation.
Regarding collagen type II, an upregulation of approxi-
mately 30-fold was noticed from 4 to 8 weeks, and the
same upregulation profile was identified for aggrecan,
in this case with a 9-fold increase. ASC revealed no Sox9
expression at all time points, and collagen type I was
also maintained at residual levels. Collagen type II
experienced a 58-fold upregulation, and aggrecan
evidenced only a slight increase from 4 to 8 weeks of
implantation. Regarding the constructs with articular
chondrocytes, no Sox9 was again detected, and collagen
type I was noticed after 4 weeks but was downregulated
approximately fourfold after 8 weeks. The same pattern
of variation was observed with collagen type II and
aggrecan, which exhibited a downregulation of two- and
threefold from 4 to 8 weeks of implantation. Gellan gum
alone did not present Sox9 transcripts and collagen type
I levels were also residual. Collagen type II and
aggrecan showed an upregulation of 13- and 2-fold,
respectively. Finally, the empty defect showed no
existence of Sox9, and evidenced a slight upregulation
of collagen type I levels from 4 to 8 weeks. Collagen type
II was upregulated 1.6-fold and aggrecan was also
upregulated 1.8-fold. In terms of higher gene tran-
scription levels after 8 weeks, the empty defect group
showed the highest values for collagen type I; AC,
followed by ASCþGF and ASC presented the highest
collagen type II expression profiles, and ASCþGF
followed by AC had the best results regarding aggrecan
levels.
DISCUSSION
In this work, injectable gellan gum hydrogels combined
with autologous cells were studied for the treatment
of rabbit articular cartilage defects. After 1 week, the
implants were similar in appearance, exhibiting a
faint opaque white color, being this occurrence more
pronounced and homogeneous in gellan gum with
encapsulated cells (ASCþGF, ASC, AC). Even so, the
gel transparency was still noticeable in all constructs.
After 4 weeks, the white opaque nature of the
defects was even more pronounced in the cell-loaded
constructs when compared to gellan alone and empty
defects, being this pattern also observed after 8 weeks.
Figure 4. Optical microscopy
pictures of histological sections of
the explant after 8 weeks of culture
stained with alcian blue (I, implant
region; NC, native cartilage; scale
bar¼200mm).
Figure 5. Graphical representation of
the results obtained with the Pineda
scoring on the explanted gellan gum-cell
constructs after 1, 4, and 8 weeks of
implantation (* statistical significant for
a statistical level of 0.05 determined by
one-way ANOVA with Tukey correction).
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The defects were homogeneously filled and well inte-
grated with the surrounding cartilage presenting
smooth transition zones between the implant and the
native tissue in ASCþGF, ASC, AC. The results
for gellan gum alone and the empty defects were more
heterogeneous. The morphological appearance was
much similar to the lateral native cartilage in those
groups than in gellan gum alone and empty defects,
particularly after 8 weeks of implantation, which
demonstrates a difference between the constructs
with cells and without cells. The staining of
histological sections of the explants revealed the
implants were all kept at the implantation site, even
though unrestricted movement of the animals was
permitted right after the surgeries. Therefore, gellan
gum constructs are able to be injected, remain, and
adapt to articular cartilage defects under normal load
bearing conditions. A progressive integration was
observed in all the constructs throughout the implanta-
tion periods. Both the osteochondral junction and the
lateral native cartilage presented a continuous tissue
bridging with the implants. The best results were
observed for the cell containing gels mostly in prolonged
stages of implantation. These results were somehow
predictable since the cells incorporated are expected to
confer an improved advantage in tissue formation and
integration due to their autologous nature and the role
they can develop in tissue rebuilding. Histological
analyses suggest that in terms of cell morphology and
overall cartilage tissue structure ASCþGF and ASC
have performed as well or better than AC and the other
constructs. The histological scoring system reinforced
some of the conclusions obtained with macroscopic and
histological analysis. The ASCþGF constructs had the
best scores in terms of values calculated from the
average of the individual scores of five independent
researchers. However, the quality of the tissue formed
at the end of the experiments was not statistically
different between the different groups (p> 0.05), with
the exception of the empty defects regarding the cell
containing constructs, according to ANOVA analysis
p<0.05. After 8 weeks of implantation, ASCþGF
appear to perform better than ASC, which suggests
the importance that the chondrogenic predifferentiation
environment may have in the final performance of the
constructs. When compared to AC, both constructs with
ASC appear to perform better in terms of absolute
scoring values of the progression of the quality and
integrity of the newly formed tissue. Real-time PCR
analyses did not detect Sox9 transcripts in any of
the samples during the course of the experiments.
Previous studies have suggested its association with the
chondrocyte phenotype maintenance and collagen
type II expression, although this is not completely
consensual.29,30 Further studies should be conducted for
a full gene transcription profiling of the implants,
influence of in vitro expansion on markers expression,
and tracking of other markers of the chondrocytes cell
cycle. Collagen type I presence only in the initial periods
in AC and residual for ASCþGF, ASC, and gellan is in
Figure 6. Graphical representa-
tion of the real-time semi-quantita-
tive PCR analysis results for Sox9,
collagen type I, collagen type II,
and aggrecan performed on the
explants collected after 1, 4, and
8 weeks of implantation.
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agreement with the formation of a cartilage tissue of
hyaline nature. The detection and maintenance of
collagen type I levels in the empty defects indicates
otherwise. In fact, the creation of this defect resembles
to some extent the Pridie drilling and microfracture
surgical techniques applied to the treatment of cartilage
pathologies.31,32 The outcome of this and similar
surgical procedures is frequently the formation of a
fibrocartilage tissue with inferior mechanical proper-
ties, and therefore the upregulation of collagen type I
levels typical of fibrocartilage was expected.31,32 Colla-
gen type II and aggrecan presented the highest levels in
gellan gum-AC constructs although exhibiting a
decrease from 4 to 8 weeks of implantation. This could
be associated to an eventual hypertrophy of chondro-
cytes, which carries a decrease in collagen type II
values.33 Nonetheless, collagen type II levels are still
significantly higher than for all the other constructs.
The same is not true for aggrecan. ASCþGF presented
the highest values for aggrecan expression with a
steadily upregulation until the final implantation
period. The same pattern of variation was observed for
collagen type II which opens good prospects for the
generation of a fully functional tissue engineered
construct since these two molecules confer cartilage
with its load bearing functions. ASC showed the same
upregulation pattern in collagen type II but not in
aggrecan which may be related with the prior chondro-
genic stimulation given to ASCþGF. Altogether, these
results suggest that gellan gum constructs combined
with different cell types have potential application in
the treatment of articular cartilage defects. Promising
results were obtained with ASC preconditioned to
chondrogenic differentiation in vitro, which may
open the opportunity for clinically treating a defect
without the disadvantages of a cartilage biopsy for
chondrocyte isolation. Their performance should be
further optimized by varying the culture cocktails
and exploiting other cells parameters (number, stage,
and subpopulation). The study through longer implan-
tation periods and inclusion of other relevant
controls, such as mosaicplasty, autologous chondrocyte
implantation (ACI), and matrix-assisted autologous
chondrocyte implantation (MACI), for example, should
be conducted to compare and confirm the results
obtained so far.
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